Healthplus.ai key facts
- Developer of a surgical patient risk management platform designed to enable proactive surgical care through personalized complication predictions.
- It has raised $2.8M; the latest was Later Stage VC ($2.7M) in Nov 2025.
- Notable investors include European Commission, Lumo Labs, Caelestinus, Leistone, Cedars-Sinai Accelerator — 11 tracked in total.
- Status: Privately Held (backing).
Who backs Healthplus.ai
11+- ·The complete investor list: 11 names
- ·Watch Healthplus.ai: the Monday email on marks, rounds and moves
Healthplus.ai funding rounds
No funding rounds for Healthplus.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Healthplus.ai investors
11 investors are on record for Healthplus.ai, including European Commission, Lumo Labs, Caelestinus and Leistone.
About Healthplus.ai
Developer of a surgical patient risk management platform designed to enable proactive surgical care through personalized complication predictions. The company's AI-based cloud platform integrates with local EHR workflow and uses machine learning algorithms to aid clinical staff in predicting early warning of post-surgery infections and other major complications, enabling healthcare professionals to provide patients with prioritized health support and improved surgical outcomes at affordable costs.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2017
- Employees
- 15
- Website
- healthplus.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Healthplus.ai doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.